Paradigm Biopharmaceuticals Ltd.ASX: PAR

iPPS shows 3-year equivalent durability in OA Canine Study

Jun 1, 2023 at 2:42 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment